High-Dose Vitamin D Induction in Optic Neuritis

NCT03302585 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped inability to meet recruitment goals

Conditions

Optic Neuritis

Interventions

DRUG: Vitamin D3
DRUG: Placebo/Standard of Care Vitamin D3

Sponsor

University of Calgary